Search
for
Sort by
Research 30 of 1000+
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of 5-alpha-dihydrotestosterone in human serum and plasma
- Novel inhibitors of 5α-reductase
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- New 5?-reductase inhibitors: In vitro and in vivo effects
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- 5α-Reduced glucocorticoids: a story of natural selection
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Side gland of Suncus murinus as a new model of sebaceous gland: 5?-reductase, androgen receptor, and nuclear androgen content in male and female animals
- 17-Oximino-5-androsten-3β-yl esters: synthesis, antiproliferative activity, acute toxicity, and effect on serum androgen level
- In silico structural prediction of human steroid 5α-reductase type II
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Intracrine androgen biosynthesis, metabolism and action revisited
- Identification of a Rare Variant in the <i>SRD5A2</i> Gene in Siblings With 46,XY Disorders of Sexual Development
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Optimization and Transfollicular Delivery of Finasteride-Loaded Proniosomes for Hair Growth Stimulation in C57BL/6Mlac Mice
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Development and validation of an UPLC method for determination of content uniformity in low-dose solid drugs products using the design space approach